Tfc Financial Management Blueprint Medicines Corp Call Options Transaction History
Tfc Financial Management
- $650 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
385Shares Held
61.5MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$583 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$572 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$489 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$215 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$167 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.14B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...